<SEC-DOCUMENT>0001096906-25-000570.txt : 20250423
<SEC-HEADER>0001096906-25-000570.hdr.sgml : 20250423
<ACCEPTANCE-DATETIME>20250423134111
ACCESSION NUMBER:		0001096906-25-000570
CONFORMED SUBMISSION TYPE:	PX14A6G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250423
DATE AS OF CHANGE:		20250423
EFFECTIVENESS DATE:		20250423

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				221024240
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		PX14A6G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-03215
		FILM NUMBER:		25860702

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		732-524-2455

	MAIL ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bowyer Research, Inc.
		CENTRAL INDEX KEY:			0001996368
		ORGANIZATION NAME:           	
		EIN:				463874783
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PX14A6G

	BUSINESS ADDRESS:	
		STREET 1:		PO BOX 120
		CITY:			MCKEESPORT
		STATE:			PA
		ZIP:			15135
		BUSINESS PHONE:		412-751-8603

	MAIL ADDRESS:	
		STREET 1:		PO BOX 120
		CITY:			MCKEESPORT
		STATE:			PA
		ZIP:			15135
</SEC-HEADER>
<DOCUMENT>
<TYPE>PX14A6G
<SEQUENCE>1
<FILENAME>bowy_px14a6g.htm
<DESCRIPTION>BOWYER RESEARCH - PX14A6G
<TEXT>
<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2024 [PPXK5GW761L0VEWPD92X]. www.edgarsuite.com -->
<HEAD>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><P align=center style='font:15pt Times New Roman;margin:0'><A name=_Hlk196288412 /><B>Notice of Exempt Solicitation</B></P>
<P align=center style='font:11pt Times New Roman;margin:0'>Pursuant to Rule 14a-103 | April 23, 2025</P>
<P style='font:11pt Times New Roman;margin:0'> &nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><B>Name of Registrant:</B> Johnson &amp; Johnson</P>
<P style='font:11pt Times New Roman;margin:0'><B>Name of person relying on exemption:</B> Bowyer Research</P>
<P style='font:11pt Times New Roman;margin:0'><B>Address of person relying on exemption: </B>P.O. Box 120, McKeesport, PA 15135</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><I>Written materials are submitted pursuant to Rule 14a-6(g) (1) promulgated under the Securities Exchange Act of 1934. Filer of this notice does not beneficially own more than $5 million of securities in the Registrant company. Submission is not required of this filer under the terms of the Rule but is made voluntarily in the interest of public disclosure and consideration of these important issues.</I></P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'><IMG src=bowypx14a6g_1.jpg width=594 height=81>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:11pt Times New Roman;margin:0'><B> Johnson &amp; Johnson (JNJ)</B></P>
<P align=center style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:0pt'><B>Resist Activist Mission Creep: Vote NO on Proposal 5</B></P>
<P align=center style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:0pt'>Contact: Gerald Bowyer | jerrybowyer@bowyerresearch.com</P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:0pt'><FONT style=background-color:#FFB064> &nbsp;&nbsp;&nbsp;&nbsp;</FONT> &nbsp;<B>Resolution</B></P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:0pt'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Bowyer Research urges Johnson &amp; Johnson shareholders to vote <B>NO</B> on Proposal #5, &#8220;Produce a Human Rights Impact Assessment.&#8221;</P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:0pt'><FONT style=background-color:#FFB064> &nbsp;&nbsp;&nbsp;&nbsp;</FONT> &nbsp;<B>Background</B></P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:12pt;background-color:#FFFFFF'>While debates over corporate human rights policies have their place, particularly among legitimate non-activist shareholders who invest for purpose of return, there&#8217;s no question that such debates are often hijacked by profoundly unrealistic activist demands that view human rights as synonymous with moving in ideological lockstep toward one side of the political aisle.</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:12pt;background-color:#FFFFFF'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:12pt;background-color:#FFFFFF'>Proposal 5 is just such an example. Submitted by Mercy Investment Services, the proposal asks Johnson &amp; Johnson to report on how it respects human rights impacts in the area of access to medicine. Yet the asks contained within evince a view of corporate human rights philosophy that values adherence to partisan dogma more than genuine human rights issues related to product access. Proposal 5 represents the kind of activist scrutiny that will not forward the best interests and drag valuable resources away from ensuring the continued success of Johnson &amp; Johnson (and the continued healthcare access that such success demonstrably provides). </P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:0pt'><FONT style=background-color:#FFB064> &nbsp;&nbsp;&nbsp;&nbsp;</FONT> &nbsp;<B>The Claims Do Not Match the Evidence</B></P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:12pt;background-color:#FFFFFF'>The activists behind Proposal 5 cite elements such as the United Nations International Covenant on Economic, Social, and Cultural Rights to imply that Johnson &amp; Johnson is somehow negligent for upholding<SUP><A name=_ftnb1 /><A href=#_ftnf1><SUP>1</SUP></A></SUP> healthcare access on a timeline that prioritizes the company&#8217;s fiduciary responsibilities. Yet its arguments don&#8217;t line up with its claims. The proponent maintains that &#8220;some of J&amp;J&#8217;s actions appear to undermine its commitment to the human right to health and access to medicines,&#8221; indicating that their true problem is not with Johnson &amp; Johnson&#8217;s actual work to ensure access to products, but with Johnson &amp; Johnson&#8217;s actions that don&#8217;t line up with the social/political views of the proponent.</P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:12pt;background-color:#FFFFFF'>For example: the proponent asserts as evidence that &#8220;A trade association to which J&amp;J belongs&#8230; supported a group that fought to repeal Obamacare.&#8221; The evidence provided? New York Times reporting<SUP><A name=_ftnb2 /><A href=#_ftnf2><SUP>2</SUP></A></SUP> indicating that &#8220;Johnson &amp; Johnson gave $35,000 that year to the Republican Main Street Partnership, a 501(c)(4) that describes itself as a coalition of lawmakers committed to &#8220;conservative, pragmatic government,&#8221; the [Center for Political Accountability] data shows.&#8221;</P>
<HR style=text-align:left;width:25%><P style='font:9pt Times New Roman;margin:0'><SUP><A name=_ftnf1 /><A href=#_ftnb1><SUP>1</SUP></A></SUP>https://www.jnj.com/latest-news/4-things-to-know-about-johnson-and-johnson-2023-health-for-humanity-report</P>
<P style='font:9pt Times New Roman;margin:0'><SUP><A name=_ftnf2 /><A href=#_ftnb2><SUP>2</SUP></A></SUP> https://www.nytimes.com/2018/07/27/business/the-stealth-campaign-to-kill-off-obamacare.html</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:12pt;background-color:#FFFFFF'>So the barrier to Johnson &amp; Johnson&#8217;s human rights commitments, in the proponent&#8217;s view, is the company daring to donate to right-of-center organizations &#8212;&nbsp;despite the Company expressly stating<SUP><A name=_ftnb3 /><A href=#_ftnf3><SUP>3</SUP></A></SUP> that &#8220;we seek to support candidates who recognize the importance of medical innovation in improving lives and that a fair, market based system provides the best environment for continued innovation.&#8221; This is conflating a company&#8217;s political expenditures with its commitments to both shareholder value and fiduciary duty &#8212;&nbsp;a profoundly unserious position that more than justifies the Board&#8217;s opposition to it.</P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:0pt'><FONT style=background-color:#FFB064> &nbsp;&nbsp;&nbsp;&nbsp;</FONT> &nbsp;<B>Conclusion</B></P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:0pt'> We don&#8217;t believe that the company has to choose between human rights and creating human flourishing through the impact of its products. Activist narratives like the ones in Proposal No. 5 represent the kind of narrow either-or thinking that Johnson &amp; Johnson has made a career out of rejecting, and epitomize the sort of non-fiduciary, unseriously-argued demands that can easily pull a company off course.
</P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:0pt'> It&#8217;s laudable that the company is so
vocal<SUP><A name=_ftnb4 /><A href=#_ftnf4><SUP>4</SUP></A></SUP> in opposing its demands &#8212;&nbsp;but we also urge shareholders, in the name of fiduciary focus and rejecting tangential activist ideology, to vote
<B> AGAINST
</B> proposal no. 5.
</P>
<P style='font:11pt Times New Roman;margin-top:12pt;margin-bottom:0pt'><FONT style=background-color:#FFB064> &nbsp;&nbsp;&nbsp;</FONT> &nbsp;<B>Disclosures/Media</B></P>
<P style='font:11pt Times New Roman;margin:0'> &nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><I>The foregoing information may be disseminated to shareholders via telephone, U.S. mail, e-mail, certain websites and certain social media venues, and should not be construed as investment advice or as a solicitation of authority to vote your proxy. The cost of disseminating the foregoing information to shareholders is being borne entirely by the filers.</I></P>
<P style='font:7pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><I>The information contained herein has been prepared from sources believed reliable but is not guaranteed by us as to its timeliness or accuracy, and is not a complete summary or statement of all available data. This piece is for informational purposes and should not be construed as a research report. Bowyer Research is not able to vote your proxies, nor does this communication contemplate such an event. Proxy cards will not be accepted by us. Please do not send your proxy to us. To vote your proxy, please follow the instructions on your proxy card.</I></P>
<P style='font:8pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>For questions, please contact Gerald Bowyer, president of Bowyer Research, via email at <FONT style='border-bottom:1px solid #000000'>jerrybowyer@bowyerresearch.com</FONT>.</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<HR style=text-align:left;width:25%><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:9pt><SUP><A name=_ftnf3 /><A href=#_ftnb3><SUP>3</SUP></A></SUP> https://www.investor.jnj.com/governance/political-engagement/default.aspx</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><SUP><A name=_ftnf4 /><A href=#_ftnb4><SUP>4</SUP></A></SUP> https://www.jnj.com/download/johnson-johnson-2025-proxy.pdf</P>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>bowypx14a6g_1.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 bowypx14a6g_1.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "2!"L# 2(  A$! Q$!_\0
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M38H@9;F3>>IR>*P=64OX:^;V-%!+XB%KNZO24MT*)ZC_ !J2+2!UFD)/HO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[-Y(E@C98X5_$FLRZLI+7!8AD/&X5U5J<XP4;:(QIRBY-WU8R3_D!7G^\O\
M,5F:3_R%K;_?K3D_Y =Y_O+_ #%9FD_\A:V_WZXZG\6G\OS9T4_X<_ZZ&CXG
M_P!?;_[K?SK!KL]2TZWU!D5Y2DR@[,'M]*YZ[T2\M<L$\U!_$G/Z56-P]3VD
MJB5T&&K0Y%%O4S:O:1<M:ZE$<X5SL8>QJCT.*LV$+3W\$:CG>"?8 YKCI-JH
MG'>YT5$G!W-GQ+:C$5THYSL;W]/ZUSM==X@Q_9+Y_OKC\ZY&NG,(J-=VZF.$
MDW2U-/0!G5X_96/Z5V%<GX<7.J$^D9_F*ZRO0RU?N?F<F,_B?(****] Y HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@"KJ"[K&7V&:P*Z:9=\,B^JD5S->=C5[R9UX=Z-%_26Q=LO]Y:EU*WDFNH_+
M0L2N/UJI8-MOHCZG%:U]<O:PAD4$L<9/:G2Y94&I;)BG=5-"K'806R>9=."?
M3M_]>HY]48C9;J$4=R.:HR2O,^Z1BQ]Z96$J]ERTU9?B:*G?6>I,+JX#[O.?
M/UK5G<7&DF0CDJ#^-8E:UT?LVE)"?O, ,?J:NA-\L[[6)J15XV,Z3_D!WGU7
M^8K-TG_D+6W^_6E)_P @2]^J_P ZS=)_Y"UM_OUR5/XM/Y?FSII_PY_UT-+Q
M,2MS;%200K8(^HJK::_=V^%EQ,G^UU_.K/B?_7V_^ZW\Q6#1B:LZ>(DX.W_#
M!0A&=%*2.S,6GZA:+=RPH4*[BQ&"/7)%+;C3+-2\#P(".6#C-97AR[!\RRDY
M5AN4']165J-F;*^DAQ\N<H?8UU2Q*C3C6C%-]?4P5&\W3<G_ , O:WJB7K+!
M <Q(<EO[QK'HHKRZM656;G([J<%"/*C<\,KF[G;TC _6NGKF_#"_O+EO91_.
MNDKW,O7[A?/\SS,4_P!ZPHHHKM.8**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH W/B#XUU31M:M=,T:5%E,>Z7,8<EF.%'/T_6NIU37QX6\+Q7NK/Y]V$5"J
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MR)%?[I&1"0@P.3CH*ZZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M16+_ &M<>D?Y'_&C^UKCTC_(_P"-'UNF'L)FU16+_:UQZ1_D?\:/[6N/2/\
M(_XT?6Z8>PF;5%8O]K7'I'^1_P :/[6N/2/\C_C1];IA["9M45B_VM<>D?Y'
M_&C^UKCTC_(_XT?6Z8>PF;5%8O\ :UQZ1_D?\:/[6N/2/\C_ (T?6Z8>PF;5
M%8O]K7'I'^1_QH_M:X](_P C_C1];IA["9M45B_VM<>D?Y'_ !H_M:X](_R/
M^-'UNF'L)FU16+_:UQZ1_D?\:/[6N/2/\C_C1];IA["9M45B_P!K7'I'^1_Q
MH_M:X](_R/\ C1];IA["9M45B_VM<>D?Y'_&C^UKCTC_ "/^-'UNF'L)FU16
M+_:UQZ1_D?\ &C^UKCTC_(_XT?6Z8>PF;5%8O]K7'I'^1_QH_M:X](_R/^-'
MUNF'L)FU16+_ &M<>D?Y'_&C^UKCTC_(_P"-'UNF'L)FU16+_:UQZ1_D?\:/
M[6N/2/\ (_XT?6Z8>PF;5%8O]K7'I'^1_P :/[6N/2/\C_C1];IA["9M45B_
MVM<>D?Y'_&C^UKCTC_(_XT?6Z8>PF;5%9$.ISR3(A"89@#@5KUM3JQJ*\2)P
M<=PHHHK0@**** "D(!&#TI:* *,]EU:+_OG_  JCC!P>M;E03VR3#/1O6@#*
MHI\D3Q-M<?0^M3V]F9/FD^5?3N:0B&&%YFPHX[D]!6E!;I".!EN[&I%144*H
M  ["G4QA1110 4444 %%%% !6/J,$TEV62-F&T<@5L45G5IJI'E9<)\CNCG/
MLEQ_SPD_[YH^R7'_ #PD_P"^:Z.BN;ZE'N:_6'V.<^R7'_/"3_OFC[)<?\\)
M/^^:Z.BCZE'N'UA]CG/LEQ_SPD_[YH^R7'_/"3_OFNCHH^I1[A]8?8YS[)<?
M\\)/^^:/LEQ_SPD_[YKHZ*/J4>X?6'V.<^R7'_/"3_OFC[)<?\\)/^^:Z.BC
MZE'N'UA]CG/LEQ_SPD_[YH^R7'_/"3_OFNCHH^I1[A]8?8YS[)<?\\)/^^:/
MLEQ_SPD_[YKHZ*/J4>X?6'V.<^R7'_/"3_OFC[)<?\\)/^^:Z.BCZE'N'UA]
MCG/LEQ_SPD_[YH^R7'_/"3_OFNCHH^I1[A]8?8YS[)<?\\)/^^:/LEQ_SPD_
M[YKHZ*/J4>X?6'V.<^R7'_/"3_OFC[)<?\\)/^^:Z.BCZE'N'UA]CG/LEQ_S
MPD_[YH^R7'_/"3_OFNCHH^I1[A]8?8YS[)<?\\)/^^:/LEQ_SPD_[YKHZ*/J
M4>X?6'V.<^R7'_/"3_OFC[)<?\\)/^^:Z.BCZE'N'UA]CG/LEQ_SPD_[YH^R
M7'_/"3_OFNCHH^I1[A]8?8YS[)<?\\)/^^:/LEQ_SPD_[YKHZ*/J4>X?6'V.
M<^R7'_/"3_OFC[)<?\\)/^^:Z.BCZE'N'UA]CG/LEQ_SPD_[YH^R7'_/"3_O
MFNCHH^I1[A]8?8YS[)<?\\)/^^:/LEQ_SPD_[YKHZ*/J4>X?6'V.<^R7'_/"
M3_OFC[)<?\\)/^^:Z.BCZE'N'UA]CG/LEQ_SPD_[YH^R7'_/"3_OFNCHH^I1
M[A]8?8YS[)<?\\)/^^:/LEQ_SPD_[YKHZ*/J4>X?6'V.<^R7'_/"3_OFC[)<
M?\\)/^^:Z.BCZE'N'UA]CG/LEQ_SPD_[YH^R7'_/"3_OFNCHH^I1[A]8?8YS
M[)<?\\)/^^:/LEQ_SPD_[YKHZ*/J4>X?6'V.<^R7'_/"3_OFC[)<?\\)/^^:
MZ.BCZE'N'UA]CG/LEQ_SPD_[YH^R7'_/"3_OFNCHH^I1[A]8?8YS[)<?\\)/
M^^:/LEQ_SPD_[YKHZ*/J4>X?6'V.<^R7'_/"3_OFC[)<?\\)/^^:Z.BCZE'N
M'UA]CG/LEQ_SPD_[YH^R7'_/"3_OFNCHH^I1[A]8?8YS[)<?\\)/^^:/LEQ_
MSPD_[YKHZ*/J4>X?6'V.<^R7'_/"3_OFC[)<?\\)/^^:Z.BCZE'N'UA]CG/L
MEQ_SPD_[YH^R7'_/"3_OFNCHH^I1[A]8?8YS[)<?\\)/^^:/LEQ_SPD_[YKH
MZ*/J4>X?6'V.<^R7'_/"3_OFC[)<?\\)/^^:Z.BCZE'N'UA]CG/LEQ_SPD_[
MYH^R7'_/"3_OFNCHH^I1[A]8?8YS[)<?\\)/^^:/LEQ_SPD_[YKHZ*/J4>X?
M6'V.<^R7'_/"3_OFC[)<?\\)/^^:Z.BCZE'N'UA]CG/LEQ_SPD_[YH^R7'_/
M"3_OFNCHH^I1[A]8?8YS[)<?\\)/^^:/LEQ_SPD_[YKHZ*/J4>X?6'V.<^R7
M'_/"3_OFC[)<?\\)/^^:Z.BCZE'N'UA]CG/LEQ_SPD_[YH^R7'_/"3_OFNCH
MH^I1[A]8?8YS[)<?\\)/^^:/LEQ_SPD_[YKHZ*/J4>X?6'V.<^R7'_/"3_OF
MC[)<?\\)/^^:Z.BCZE'N'UA]CG/LEQ_SPD_[YH^R7'_/"3_OFNCHH^I1[A]8
M?8YS[)<?\\)/^^:/LEQ_SPD_[YKHZ*/J4>X?6'V.<^R7'_/"3_OFC[)<?\\)
M/^^:Z.BCZE'N'UA]CG/LEQ_SPD_[YH^R7'_/"3_OFNCHH^I1[A]8?8YS[)<?
M\\)/^^:/LEQ_SPD_[YKHZ*/J4>X?6'V.<^R7'_/"3_OFC[)<?\\)/^^:Z.BC
MZE'N'UA]CG/LEQ_SPD_[YH^R7'_/"3_OFNCHH^I1[A]8?8YS[)<?\\)/^^:/
MLEQ_SPD_[YKHZ*/J4>X?6'V.<^R7'_/"3_OFC[)<?\\)/^^:Z.BCZE'N'UA]
MCG/LEQ_SPD_[YH^R7'_/"3_OFNCHH^I1[A]8?8YS[)<?\\)/^^:/LEQ_SPD_
M[YKHZ*/J4>X?6'V.<^R7'_/"3_OFC[)<?\\)/^^:Z.BCZE'N'UA]C M[6=;F
M,F%P P))'O6_116]&BJ2:3,IU'/<****V("BBB@ HHHH **** &D!NH!Y[TZ
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
<* "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
